Renal Disease Market Segmentation
Renal Disease Market Type Outlook (USD Billion, 2019-2030)
Chronic Kidney Disease
End-Stage Renal Disease
Renal Disease Market Treatment Outlook (USD Billion, 2019-2030)
Dialysis
Medication
Kidney Transplantation
Renal Disease Market End User Outlook (USD Billion, 2019-2030)
Dialysis Centers
Hospital & Clinics
Research and Academic Institutes
Renal Disease Market Regional Outlook (USD Billion, 2019-2030)
North America Outlook (USD Billion, 2019-2030)
North America Renal Disease Market by Type
Chronic Kidney Disease
End-Stage Renal Disease
North America Renal Disease Market by Treatment
Dialysis
Medication
Kidney Transplantation
North America Renal Disease Market by End User
Dialysis Centers
Hospital & Clinics
Research and Academic Institutes
US Outlook (USD Billion, 2019-2030)
US Renal Disease Market by Type
Chronic Kidney Disease
End-Stage Renal Disease
US Renal Disease Market by Treatment
Dialysis
Medication
Kidney Transplantation
US Renal Disease Market by End User
Dialysis Centers
Hospital & Clinics
Research and Academic Institutes
Canada Outlook (USD Billion, 2019-2030)
Canada Renal Disease Market by Type
Chronic Kidney Disease
End-Stage Renal Disease
Canada Renal Disease Market by Treatment
Dialysis
Medication
Kidney Transplantation
Canada Renal Disease Market by End User
Dialysis Centers
Hospital & Clinics
Research and Academic Institutes
Europe Outlook (USD Billion, 2019-2030)
Europe Renal Disease Market by Type
Chronic Kidney Disease
End-Stage Renal Disease
Europe Renal Disease Market by Treatment
Dialysis
Medication
Kidney Transplantation
Europe Renal Disease Market by End User
Dialysis Centers
Hospital & Clinics
Research and Academic Institutes
Germany Outlook (USD Billion, 2019-2030)
Germany Renal Disease Market by Type
Chronic Kidney Disease
End-Stage Renal Disease
Germany Renal Disease Market by Treatment
Dialysis
Medication
Kidney Transplantation
Germany Renal Disease Market by End User
Dialysis Centers
Hospital & Clinics
Research and Academic Institutes
France Outlook (USD Billion, 2019-2030)
France Renal Disease Market by Type
Chronic Kidney Disease
End-Stage Renal Disease
France Renal Disease Market by Treatment
Dialysis
Medication
Kidney Transplantation
France Renal Disease Market by End User
Dialysis Centers
Hospital & Clinics
Research and Academic Institutes
UK Outlook (USD Billion, 2019-2030)
UK Renal Disease Market by Type
Chronic Kidney Disease
End-Stage Renal Disease
UK Renal Disease Market by Treatment
Dialysis
Medication
Kidney Transplantation
UK Renal Disease Market by End User
Dialysis Centers
Hospital & Clinics
Research and Academic Institutes
Italy Outlook (USD Billion, 2019-2030)
Italy Renal Disease Market by Type
Chronic Kidney Disease
End-Stage Renal Disease
Italy Renal Disease Market by Treatment
Dialysis
Medication
Kidney Transplantation
Italy Renal Disease Market by End User
Dialysis Centers
Hospital & Clinics
Research and Academic Institutes
Spain Outlook (USD Billion, 2019-2030)
Spain Renal Disease Market by Type
Chronic Kidney Disease
End-Stage Renal Disease
Spain Renal Disease Market by Treatment
Dialysis
Medication
Kidney Transplantation
Spain Renal Disease Market by End User
Dialysis Centers
Hospital & Clinics
Research and Academic Institutes
Rest Of Europe Outlook (USD Billion, 2019-2030)
Rest Of Europe Renal Disease Market by Type
Chronic Kidney Disease
End-Stage Renal Disease
Rest of Europe Renal Disease Market by Treatment
Dialysis
Medication
Kidney Transplantation
Rest of Europe Renal Disease Market by End User
Dialysis Centers
Hospital & Clinics
Research and Academic Institutes
Asia-Pacific Outlook (USD Billion, 2019-2030)
Asia-Pacific Renal Disease Market by Type
Chronic Kidney Disease
End-Stage Renal Disease
Asia-Pacific Renal Disease Market by Treatment
Dialysis
Medication
Kidney Transplantation
Asia-Pacific Renal Disease Market by End User
Dialysis Centers
Hospital & Clinics
Research and Academic Institutes
China Outlook (USD Billion, 2019-2030)
China Renal Disease Market by Type
Chronic Kidney Disease
End-Stage Renal Disease
China Renal Disease Market by Treatment
Dialysis
Medication
Kidney Transplantation
China Renal Disease Market by End User
Dialysis Centers
Hospital & Clinics
Research and Academic Institutes
Japan Outlook (USD Billion, 2019-2030)
Japan Renal Disease Market by Type
Chronic Kidney Disease
End-Stage Renal Disease
Japan Renal Disease Market by Treatment
Dialysis
Medication
Kidney Transplantation
Japan Renal Disease Market by End User
Dialysis Centers
Hospital & Clinics
Research and Academic Institutes
India Outlook (USD Billion, 2019-2030)
India Renal Disease Market by Type
Chronic Kidney Disease
End-Stage Renal Disease
India Renal Disease Market by Treatment
Dialysis
Medication
Kidney Transplantation
India Renal Disease Market by End User
Dialysis Centers
Hospital & Clinics
Research and Academic Institutes
Australia Outlook (USD Billion, 2019-2030)
Australia Renal Disease Market by Type
Chronic Kidney Disease
End-Stage Renal Disease
Australia Renal Disease Market by Treatment
Dialysis
Medication
Kidney Transplantation
Australia Renal Disease Market by End User
Dialysis Centers
Hospital & Clinics
Research and Academic Institutes
South Korea Outlook (USD Billion, 2019-2030)
South Korea Renal Disease Market by Type
Chronic Kidney Disease
End-Stage Renal Disease
South Korea Renal Disease Market by Treatment
Dialysis
Medication
Kidney Transplantation
South Korea Renal Disease Market by End User
Dialysis Centers
Hospital & Clinics
Research and Academic Institutes
Rest of Asia-Pacific Outlook (USD Billion, 2019-2030)
Rest of Asia-Pacific Renal Disease Market by Type
Chronic Kidney Disease
End-Stage Renal Disease
Rest of Asia-Pacific Renal Disease Market by Treatment
Dialysis
Medication
Kidney Transplantation
Rest of Asia-Pacific Renal Disease Market by End User
Dialysis Centers
Hospital & Clinics
Research and Academic Institutes
Rest of the World Outlook (USD Billion, 2019-2030)
Rest of the World Renal Disease Market by Type
Chronic Kidney Disease
End-Stage Renal Disease
Rest of the World Renal Disease Market by Treatment
Dialysis
Medication
Kidney Transplantation
Rest of the World Renal Disease Market by End User
Dialysis Centers
Hospital & Clinics
Research and Academic Institutes
Middle East Outlook (USD Billion, 2019-2030)
Middle East Renal Disease Market by Type
Chronic Kidney Disease
End-Stage Renal Disease
Middle East Renal Disease Market by Treatment
Dialysis
Medication
Kidney Transplantation
Middle East Renal Disease Market by End User
Dialysis Centers
Hospital & Clinics
Research and Academic Institutes
Africa Outlook (USD Billion, 2019-2030)
Africa Renal Disease Market by Type
Chronic Kidney Disease
End-Stage Renal Disease
Africa Renal Disease Market by Treatment
Dialysis
Medication
Kidney Transplantation
Africa Renal Disease Market by End User
Dialysis Centers
Hospital & Clinics
Research and Academic Institutes
Latin America Outlook (USD Billion, 2019-2030)
Latin America Renal Disease Market by Type
Chronic Kidney Disease
End-Stage Renal Disease
Latin America Renal Disease Market by Treatment
Dialysis
Medication
Kidney Transplantation
Latin America Renal Disease Market by End User
Dialysis Centers
Hospital & Clinics
Research and Academic Institutes
Research Methodology on Renal Disease Market
1. Introduction
The purpose of this research is to assess the impact of renal disease on the global market. The research question is, what are the factors influencing the development of renal disease markets worldwide? Specifically, we will examine the prevalence and type of renal disease, the factors contributing to its growth, the change in trends in its diagnosis and treatment and the role of local, national and international healthcare organizations in the management and prevention of renal disease.
2. Research design
The research approach adopted in this study is qualitative in nature. Qualitative research is chosen due to the lack of quantitative data regarding the renal disease market and to obtain an in-depth understanding of the factors influencing its growth. This research design allows for a more detailed exploration and analysis of the current situation and the scope for further development.
The need to collect primary and secondary data from a variety of sources is a crucial aspect of this research. To provide a comprehensive analysis of the topic, this work is based on interviews with health professionals and experts in the field of renal disease, a review of relevant literature and archived documents, online surveys and reports by various healthcare organizations. Secondary data collection will include industry reports and other resources.
3. Sampling
The demographic profile of the sample population varies depending on the specific source used. For example, interviews are conducted with qualified health professionals and experts who have experience with the diagnosis, treatment and management of renal disease, while surveys are designed to gain a broad representation of geographical regions, different income and social backgrounds, and an overall gender breakdown.
4. Data collection
The data collection process includes:
5. Data analysis
The data collected is analyzed using a variety of analytical and data processing techniques. Descriptive analyses will be used to present the overall picture of the renal disease market. The narrative analysis will be applied to examine the opinions and experiences of the interview and survey respondents. Qualitative data analysis is used to uncover the nuances and underlying motivations of the respondents. Regression analysis is employed to identify the correlations between different factors.
6. Conclusion
This study assesses the impact of renal disease on the global market. It is based on qualitative research that looks into the prevalence and type of renal disease, the factors contributing to its growth, changes in trends in its diagnosis and treatment and the role of local, national and international healthcare organisations in the management and prevention of renal disease. Primary data is obtained through interviews and surveys while secondary data will be collected from archived documents, industry reports and other resources. The data collected is analyzed through a variety of techniques with a particular focus on qualitative data analysis to identify the nuances and underlying motivations of the respondents.
1 Executive Summary
2 Market Introduction
2.1 Scope of Study 17
2.2 Research Objective 17
2.3 List of Assumptions 18
3 Research Methodology
3.1 Research Process 20
3.2 Primary Research 21
3.3 Secondary Research 21
3.4 Market Size Estimation 23
4 Market Dynamics
4.1 Introduction 24
4.2 Drivers 25
4.2.1 Rising Prevalence of Kidney Disease 25
4.2.1 Growing Prevalence of Diabetes and Hypertension 25
4.2.2 Rapid Growth in the Geriatric Population 25
4.3 Restraints 26
4.3.1 Rising Healthcare Cost 26
4.3.2 Stringent Regulatory Policies 26
4.4 Opportunities 26
4.4.1 Expansion in Developing Economies 26
4.5 Market Trends 26
4.5.1 Artificial Intelligence (AI) for Managing and Diagnosis of Chronic Kidney Disease (CKD) 26
4.6 Macroeconomic Indicators 27
5 Market Factor Analysis
5.1 Porter’s Five Forces Analysis 28
5.1.1 Bargaining Power of Suppliers 28
5.1.2 Bargaining Power of Buyers 29
5.1.3 Threat of New Entrants 29
5.1.4 Threat of Substitutes 29
5.1.5 Intensity of Rivalry 29
5.2 Value Chain Analysis 30
5.2.1 R&D and Designing 30
5.2.2 Manufacturing 30
5.2.3 Distribution and Sales 30
5.2.4 Post-Sales Services 31
5.3 Pricing Analysis 31
5.4 Investment Opportunities 32
6 Renal Disease Market, By Disease Type
6.1 Overview 33
6.2 Chronic Kidney Disease 34
6.3 End-Stage Renal Disease (ESRD) 35
7 Renal Disease Market, By Treatment Type
7.1 Overview 36
7.2 Dialysis 37
7.3 Medication 38
7.4 Kidney Transplantation 40
8 Renal Disease Market, By End User
8.1 Overview 41
8.2 Dialysis Centres 42
8.3 Hospital & Clinics 43
8.4 Research and Academic Institutes 44
9 Global Renal Disease Market, by Region
9.1 Overview 45
9.2 Americas 47
Renal Disease Market, By Disease Type
Renal Disease Market, By Treatment Type
Renal Disease Market, By End User
9.2.1 North America 50
Renal Disease Market, By Disease Type
Renal Disease Market, By Treatment Type
Renal Disease Market, By End User
9.2.1.1 US 53
Renal Disease Market, By Disease Type
Renal Disease Market, By Treatment Type
Renal Disease Market, By End User
9.2.1.2 Canada 56
Renal Disease Market, By Disease Type
Renal Disease Market, By Treatment Type
Renal Disease Market, By End User
9.2.2 Latin America 58
Renal Disease Market, By Disease Type
Renal Disease Market, By Treatment Type
Renal Disease Market, By End User
9.3 Europe 61
Renal Disease Market, By Disease Type
Renal Disease Market, By Treatment Type
Renal Disease Market, By End User
9.3.1 Western Europe 64
Renal Disease Market, By Disease Type
Renal Disease Market, By Treatment Type
Renal Disease Market, By End User
9.3.1.1 Germany 68
Renal Disease Market, By Disease Type
Renal Disease Market, By Treatment Type
Renal Disease Market, By End User
9.3.1.2 France 70
Renal Disease Market, By Disease Type
Renal Disease Market, By Treatment Type
Renal Disease Market, By End User
9.3.1.3 UK 73
Renal Disease Market, By Disease Type
Renal Disease Market, By Treatment Type
Renal Disease Market, By End User
9.3.1.4 Italy 75
Renal Disease Market, By Disease Type
Renal Disease Market, By Treatment Type
Renal Disease Market, By End User
9.3.1.5 Spain 78
Renal Disease Market, By Disease Type
Renal Disease Market, By Treatment Type
Renal Disease Market, By End User
9.3.1.6 Rest of Western Europe 80
Renal Disease Market, By Disease Type
Renal Disease Market, By Treatment Type
Renal Disease Market, By End User
9.3.2 Eastern Europe 83
Renal Disease Market, By Disease Type
Renal Disease Market, By Treatment Type
Renal Disease Market, By End User
9.4 Asia-Pacific 86
Renal Disease Market, By Disease Type
Renal Disease Market, By Treatment Type
Renal Disease Market, By End User
9.4.1 Japan 89
Renal Disease Market, By Disease Type
Renal Disease Market, By Treatment Type
Renal Disease Market, By End User
9.4.2 China 92
Renal Disease Market, By Disease Type
Renal Disease Market, By Treatment Type
Renal Disease Market, By End User
9.4.3 India 94
Renal Disease Market, By Disease Type
Renal Disease Market, By Treatment Type
Renal Disease Market, By End User
9.4.4 South Korea 97
Renal Disease Market, By Disease Type
Renal Disease Market, By Treatment Type
Renal Disease Market, By End User
9.4.5 Australia 99
Renal Disease Market, By Disease Type
Renal Disease Market, By Treatment Type
Renal Disease Market, By End User
9.4.6 Rest of Asia-Pacific 102
Renal Disease Market, By Disease Type
Renal Disease Market, By Treatment Type
Renal Disease Market, By End User
9.5 Middle East & Africa 105
Renal Disease Market, By Disease Type
Renal Disease Market, By Treatment Type
Renal Disease Market, By End User
9.5.1 Middle East 108
Renal Disease Market, By Disease Type
Renal Disease Market, By Treatment Type
Renal Disease Market, By End User
9.5.2 Africa 111
Renal Disease Market, By Disease Type
Renal Disease Market, By Treatment Type
Renal Disease Market, By End User
10 Competitive Landscape
10.1 Introduction 114
11 Company Profiles
11.1 Abbott 116
11.1.1 Company Overview 116
11.1.2 Financial Overview 116
11.1.3 Products/Services Offered 117
11.1.4 Key Developments 117
11.1.5 SWOT Analysis 117
11.1.6 Key Strategies 117
11.2 Amgen Inc. 118
11.2.1 Company Overview 118
11.2.2 Financial Overview 118
11.2.3 Products/Services Offered 119
11.2.4 Key Developments 119
11.2.5 SWOT Analysis 120
11.2.6 Key Strategies 120
11.3 AstraZeneca 121
11.3.1 Company Overview 121
11.3.2 Financial Overview 121
11.3.3 Products/Services Offered 122
11.3.4 Key Developments 122
11.3.5 SWOT Analysis 123
11.3.6 Key Strategies 123
11.4 Bristol-Myers Squibb Company 124
11.4.1 Company Overview 124
11.4.2 Financial Overview 124
11.4.3 Products/Services Offered 124
11.4.4 Key Developments 125
11.4.5 SWOT Analysis 125
11.4.6 Key Strategies 125
11.5 F. Hoffmann-La Roche Ltd 126
11.5.1 Company Overview 126
11.5.2 Financial Overview 126
11.5.3 Products/Services Offered 127
11.5.4 Key Developments 127
11.5.5 SWOT Analysis 127
11.5.6 Key Strategies 127
11.6 Fresenius Medical Care AG & Co. KGaA 128
11.6.1 Company Overview 128
11.6.2 Financial Overview 128
11.6.3 Products/Services Offered 129
11.6.4 Key Developments 129
11.6.5 SWOT Analysis 130
11.6.6 Key Strategies 130
11.7 GlaxoSmithKline PLC 131
11.7.1 Company Overview 131
11.7.2 Financial Overview 131
11.7.3 Products/Services Offered 131
11.7.4 Key Developments 132
11.7.5 SWOT Analysis 132
11.7.6 Key Strategies 132
11.8 Keryx Biopharmaceuticals, Inc. 133
11.8.1 Company Overview 133
11.8.2 Financial Overview 133
11.8.3 Products/Services Offered 133
11.8.4 Key Developments 134
11.8.5 SWOT Analysis 134
11.8.6 Key Strategies 134
11.9 Kissei Pharmaceutical Co., Ltd 135
11.9.1 Company Overview 135
11.9.2 Financial Overview 135
11.9.3 Products/Services Offered 135
11.9.4 Key Developments 136
11.9.5 SWOT Analysis 136
11.9.6 Key Strategies 136
11.10 Novartis AG 137
11.10.1 Company Overview 137
11.10.2 Financial Overview 137
11.10.3 Products/Services Offered 137
11.10.4 Key Developments 138
11.10.5 SWOT Analysis 138
11.10.6 Key Strategies 138
11.11 Pfizer Inc. 139
11.11.1 Company Overview 139
11.11.2 Financial Overview 139
11.11.3 Products/Services Offered 140
11.11.4 Key Developments 140
11.11.5 SWOT Analysis 140
11.11.6 Key Strategies 140
11.12 Sanofi SA 141
11.12.1 Company Overview 141
11.12.2 Financial Overview 141
11.12.3 Products/Services Offered 142
11.12.4 Key Developments 142
11.12.5 SWOT Analysis 142
11.12.6 Key Strategies 142
11.13 Teva Pharmaceutical Industries Ltd 143
11.13.1 Company Overview 143
11.13.2 Financial Overview 143
11.13.3 Products/Services Offered 143
11.13.4 Key Developments 144
11.13.5 SWOT Analysis 144
11.13.6 Key Strategies 144
12 Appendix
12.1 Discussion Blue Print 145
13 List of Tables
TABLE 1 MARKET SYNOPSIS 16
TABLE 2 LIST OF ASSUMPTIONS 18
TABLE 3 PRIMARY INTERVIEWS 21
TABLE 4 PRICING RANGE OF KIDNEY TREATMENT (ANNUAL COST) 31
TABLE 5 GLOBAL RENAL DISEASE MARKET, BY DISEASE TYPE, 2023-2030 (USD MILLION) 33
TABLE 6 GLOBAL RENAL DISEASE MARKET, FOR CHRONIC KIDNEY DISEASE, BY REGION, 2023-2030 (USD MILLION) 34
TABLE 7 GLOBAL RENAL DISEASE MARKET, FOR END-STAGE RENAL DISEASE (ESRD), BY REGION, 2023-2030 (USD MILLION) 35
TABLE 8 GLOBAL RENAL DISEASE MARKET, BY TREATMENT TYPE, 2023-2030 (USD MILLION) 36
TABLE 9 GLOBAL RENAL DISEASE MARKET, FOR DIALYSIS, BY REGION, 2023-2030 (USD MILLION) 37
TABLE 10 GLOBAL RENAL DISEASE MARKET, FOR MEDICATION, BY TYPE, 2023-2030 (USD MILLION) 38
TABLE 11 GLOBAL RENAL DISEASE MARKET, FOR ANTIHYPERTENSIVE DRUGS, BY TYPE, 2023-2030 (USD MILLION) 39
TABLE 12 GLOBAL RENAL DISEASE MARKET, FOR MEDICATION, BY REGION, 2023-2030 (USD MILLION) 39
TABLE 13 GLOBAL RENAL DISEASE MARKET, FOR KIDNEY TRANSPLANTATION, BY REGION, 2023-2030 (USD MILLION) 40
TABLE 14 GLOBAL RENAL DISEASE MARKET, BY END USER, 2023-2030 (USD MILLION) 41
TABLE 15 GLOBAL RENAL DISEASE MARKET, FOR DIALYSIS CENTRES, BY REGION, 2023-2030 (USD MILLION) 43
TABLE 16 GLOBAL RENAL DISEASE MARKET, FOR HOSPITAL & CLINICS, BY REGION, 2023-2030 (USD MILLION) 43
TABLE 17 GLOBAL RENAL DISEASE MARKET, FOR RESEARCH AND ACADEMIC INSTITUTES, BY REGION, 2023-2030 (USD MILLION) 44
TABLE 18 GLOBAL RENAL DISEASE MARKET, BY REGION, 2023-2030 (USD MILLION) 45
TABLE 19 AMERICAS: RENAL DISEASE MARKET, BY REGION, 2023-2030 (USD MILLION) 47
TABLE 20 AMERICAS: RENAL DISEASE MARKET, BY DISEASE TYPE, 2023-2030 (USD MILLION) 48
TABLE 21 AMERICAS: RENAL DISEASE MARKET, BY TREATMENT TYPE, 2023-2030 (USD MILLION) 48
TABLE 22 AMERICAS: RENAL DISEASE MARKET, FOR MEDICATION, BY TYPE, 2023-2030 (USD MILLION) 49
TABLE 23 AMERICAS: RENAL DISEASE MARKET, FOR ANTIHYPERTENSIVE DRUGS, BY TYPE, 2023-2030 (USD MILLION) 49
TABLE 24 AMERICAS: RENAL DISEASE MARKET, BY END USER, 2023-2030 (USD MILLION) 50
TABLE 25 NORTH AMERICA: RENAL DISEASE MARKET, BY COUNTRY, 2023-2030 (USD MILLION) 50
TABLE 26 NORTH AMERICA: RENAL DISEASE MARKET, BY DISEASE TYPE, 2023-2030 (USD MILLION) 51
TABLE 27 NORTH AMERICA: RENAL DISEASE MARKET, BY TREATMENT TYPE, 2023-2030 (USD MILLION) 51
TABLE 28 NORTH AMERICA: RENAL DISEASE MARKET, FOR MEDICATION, BY TYPE, 2023-2030 (USD MILLION) 52
TABLE 29 NORTH AMERICA: RENAL DISEASE MARKET, FOR ANTIHYPERTENSIVE DRUGS, BY TYPE, 2023-2030 (USD MILLION) 52
TABLE 30 NORTH AMERICA: RENAL DISEASE MARKET, BY END USER, 2023-2030 (USD MILLION) 53
TABLE 31 US: RENAL DISEASE MARKET, BY DISEASE TYPE, 2023-2030 (USD MILLION) 53
TABLE 32 US: RENAL DISEASE MARKET, BY TREATMENT TYPE, 2023-2030 (USD MILLION) 54
TABLE 33 US: RENAL DISEASE MARKET, FOR MEDICATION, BY TYPE, 2023-2030 (USD MILLION) 54
TABLE 34 US: RENAL DISEASE MARKET, FOR ANTIHYPERTENSIVE DRUGS, BY TYPE, 2023-2030 (USD MILLION) 55
TABLE 35 US: RENAL DISEASE MARKET, BY END USER, 2023-2030 (USD MILLION) 55
TABLE 36 CANADA: RENAL DISEASE MARKET, BY DISEASE TYPE, 2023-2030 (USD MILLION) 56
TABLE 37 CANADA: RENAL DISEASE MARKET, BY TREATMENT TYPE, 2023-2030 (USD MILLION) 56
TABLE 38 CANADA: RENAL DISEASE MARKET, FOR MEDICATION, BY TYPE, 2023-2030 (USD MILLION) 57
TABLE 39 CANADA: RENAL DISEASE MARKET, FOR ANTIHYPERTENSIVE DRUGS, BY TYPE, 2023-2030 (USD MILLION) 57
TABLE 40 CANADA: RENAL DISEASE MARKET, BY END USER, 2023-2030 (USD MILLION) 58
TABLE 41 LATIN AMERICA: RENAL DISEASE MARKET, BY DISEASE TYPE, 2023-2030 (USD MILLION) 58
TABLE 42 LATIN AMERICA: RENAL DISEASE MARKET, BY TREATMENT TYPE, 2023-2030 (USD MILLION) 59
TABLE 43 LATIN AMERICA: RENAL DISEASE MARKET, FOR MEDICATION, BY TYPE, 2023-2030 (USD MILLION) 59
TABLE 44 LATIN AMERICA: RENAL DISEASE MARKET, FOR ANTIHYPERTENSIVE DRUGS, BY TYPE, 2023-2030 (USD MILLION) 60
TABLE 45 LATIN AMERICA: RENAL DISEASE MARKET, BY END USER, 2023-2030 (USD MILLION) 60
TABLE 46 EUROPE: RENAL DISEASE MARKET, BY REGION, 2023-2030 (USD MILLION) 61
TABLE 47 EUROPE: RENAL DISEASE MARKET, BY DISEASE TYPE, 2023-2030 (USD MILLION) 62
TABLE 48 EUROPE: RENAL DISEASE MARKET, BY TREATMENT TYPE, 2023-2030 (USD MILLION) 62
TABLE 49 EUROPE: RENAL DISEASE MARKET, FOR MEDICATION, BY TYPE, 2023-2030 (USD MILLION) 63
TABLE 50 EUROPE: RENAL DISEASE MARKET, FOR ANTIHYPERTENSIVE DRUGS, BY TYPE, 2023-2030 (USD MILLION) 63
TABLE 51 EUROPE: RENAL DISEASE MARKET, BY END USER, 2023-2030 (USD MILLION) 64
TABLE 52 WESTERN EUROPE: RENAL DISEASE MARKET, BY COUNTRY, 2023-2030 (USD MILLION) 64
TABLE 53 WESTERN EUROPE: RENAL DISEASE MARKET, BY DISEASE TYPE, 2023-2030 (USD MILLION) 65
TABLE 54 WESTERN EUROPE: RENAL DISEASE MARKET, BY TREATMENT TYPE, 2023-2030 (USD MILLION) 66
TABLE 55 WESTERN EUROPE: RENAL DISEASE MARKET, FOR MEDICATION, BY TYPE, 2023-2030 (USD MILLION) 66
TABLE 56 WESTERN EUROPE: RENAL DISEASE MARKET, FOR ANTIHYPERTENSIVE DRUGS, BY TYPE, 2023-2030 (USD MILLION) 67
TABLE 57 WESTERN EUROPE: RENAL DISEASE MARKET, BY END USER, 2023-2030 (USD MILLION) 67
TABLE 58 GERMANY: RENAL DISEASE MARKET, BY DISEASE TYPE, 2023-2030 (USD MILLION) 68
TABLE 59 GERMANY: RENAL DISEASE MARKET, BY TREATMENT TYPE, 2023-2030 (USD MILLION) 68
TABLE 60 GERMANY: RENAL DISEASE MARKET, FOR MEDICATION, BY TYPE, 2023-2030 (USD MILLION) 69
TABLE 61 GERMANY: RENAL DISEASE MARKET, FOR ANTIHYPERTENSIVE DRUGS, BY TYPE, 2023-2030 (USD MILLION) 69
TABLE 62 GERMANY: RENAL DISEASE MARKET, BY END USER, 2023-2030 (USD MILLION) 70
TABLE 63 FRANCE: RENAL DISEASE MARKET, BY DISEASE TYPE, 2023-2030 (USD MILLION) 70
TABLE 64 FRANCE: RENAL DISEASE MARKET, BY TREATMENT TYPE, 2023-2030 (USD MILLION) 71
TABLE 65 FRANCE: RENAL DISEASE MARKET, FOR MEDICATION, BY TYPE, 2023-2030 (USD MILLION) 71
TABLE 66 FRANCE: RENAL DISEASE MARKET, FOR ANTIHYPERTENSIVE DRUGS, BY TYPE, 2023-2030 (USD MILLION) 72
TABLE 67 FRANCE: RENAL DISEASE MARKET, BY END USER, 2023-2030 (USD MILLION) 72
TABLE 68 UK: RENAL DISEASE MARKET, BY DISEASE TYPE, 2023-2030 (USD MILLION) 73
TABLE 69 UK: RENAL DISEASE MARKET, BY TREATMENT TYPE, 2023-2030 (USD MILLION) 73
TABLE 70 UK: RENAL DISEASE MARKET, FOR MEDICATION, BY TYPE, 2023-2030 (USD MILLION) 74
TABLE 71 UK: RENAL DISEASE MARKET, FOR ANTIHYPERTENSIVE DRUGS, BY TYPE, 2023-2030 (USD MILLION) 74
TABLE 72 UK: RENAL DISEASE MARKET, BY END USER, 2023-2030 (USD MILLION) 75
TABLE 73 ITALY: RENAL DISEASE MARKET, BY DISEASE TYPE, 2023-2030 (USD MILLION) 75
TABLE 74 ITALY: RENAL DISEASE MARKET, BY TREATMENT TYPE, 2023-2030 (USD MILLION) 76
TABLE 75 ITALY: RENAL DISEASE MARKET, FOR MEDICATION, BY TYPE, 2023-2030 (USD MILLION) 76
TABLE 76 ITALY: RENAL DISEASE MARKET, FOR ANTIHYPERTENSIVE DRUGS, BY TYPE, 2023-2030 (USD MILLION) 77
TABLE 77 ITALY: RENAL DISEASE MARKET, BY END USER, 2023-2030 (USD MILLION) 77
TABLE 78 SPAIN: RENAL DISEASE MARKET, BY DISEASE TYPE, 2023-2030 (USD MILLION) 78
TABLE 79 SPAIN: RENAL DISEASE MARKET, BY TREATMENT TYPE, 2023-2030 (USD MILLION) 78
TABLE 80 SPAIN: RENAL DISEASE MARKET, FOR MEDICATION, BY TYPE, 2023-2030 (USD MILLION) 79
TABLE 81 SPAIN: RENAL DISEASE MARKET, FOR ANTIHYPERTENSIVE DRUGS, BY TYPE, 2023-2030 (USD MILLION) 79
TABLE 82 SPAIN: RENAL DISEASE MARKET, BY END USER, 2023-2030 (USD MILLION) 80
TABLE 83 REST OF WESTERN EUROPE: RENAL DISEASE MARKET, BY DISEASE TYPE, 2023-2030 (USD MILLION) 80
TABLE 84 REST OF WESTERN EUROPE: RENAL DISEASE MARKET, BY TREATMENT TYPE, 2023-2030 (USD MILLION) 81
TABLE 85 REST OF WESTERN EUROPE: RENAL DISEASE MARKET, FOR MEDICATION, BY TYPE, 2023-2030 (USD MILLION) 81
TABLE 86 REST OF WESTERN EUROPE: RENAL DISEASE MARKET, FOR ANTIHYPERTENSIVE DRUGS, BY TYPE, 2023-2030 (USD MILLION) 82
TABLE 87 REST OF WESTERN EUROPE: RENAL DISEASE MARKET, BY END USER, 2023-2030 (USD MILLION) 82
TABLE 88 EASTERN EUROPE: RENAL DISEASE MARKET, BY DISEASE TYPE, 2023-2030 (USD MILLION) 83
TABLE 89 EASTERN EUROPE: RENAL DISEASE MARKET, BY TREATMENT TYPE, 2023-2030 (USD MILLION) 83
TABLE 90 EASTERN EUROPE: RENAL DISEASE MARKET, FOR MEDICATION, BY TYPE, 2023-2030 (USD MILLION) 84
TABLE 91 EASTERN EUROPE: RENAL DISEASE MARKET, FOR ANTIHYPERTENSIVE DRUGS, BY TYPE, 2023-2030 (USD MILLION) 84
TABLE 92 EASTERN EUROPE: RENAL DISEASE MARKET, BY END USER, 2023-2030 (USD MILLION) 85
TABLE 93 ASIA-PACIFIC: RENAL DISEASE MARKET, BY COUNTRY, 2023-2030 (USD MILLION) 86
TABLE 94 ASIA-PACIFIC: RENAL DISEASE MARKET, BY DISEASE TYPE, 2023-2030 (USD MILLION) 87
TABLE 95 ASIA-PACIFIC: RENAL DISEASE MARKET, BY TREATMENT TYPE, 2023-2030 (USD MILLION) 87
TABLE 96 ASIA-PACIFIC: RENAL DISEASE MARKET, FOR MEDICATION, BY TYPE, 2023-2030 (USD MILLION) 88
TABLE 97 ASIA-PACIFIC: RENAL DISEASE MARKET, FOR ANTIHYPERTENSIVE DRUGS, BY TYPE, 2023-2030 (USD MILLION) 88
TABLE 98 ASIA-PACIFIC: RENAL DISEASE MARKET, BY END USER, 2023-2030 (USD MILLION) 89
TABLE 99 JAPAN: RENAL DISEASE MARKET, BY DISEASE TYPE, 2023-2030 (USD MILLION) 89
TABLE 100 JAPAN: RENAL DISEASE MARKET, BY TREATMENT TYPE, 2023-2030 (USD MILLION) 90
TABLE 101 JAPAN: RENAL DISEASE MARKET, FOR MEDICATION, BY TYPE, 2023-2030 (USD MILLION) 90
TABLE 102 JAPAN: RENAL DISEASE MARKET, FOR ANTIHYPERTENSIVE DRUGS, BY TYPE, 2023-2030 (USD MILLION) 91
TABLE 103 JAPAN: RENAL DISEASE MARKET, BY END USER, 2023-2030 (USD MILLION) 91
TABLE 104 CHINA: RENAL DISEASE MARKET, BY DISEASE TYPE, 2023-2030 (USD MILLION) 92
TABLE 105 CHINA: RENAL DISEASE MARKET, BY TREATMENT TYPE, 2023-2030 (USD MILLION) 92
TABLE 106 CHINA: RENAL DISEASE MARKET, FOR MEDICATION, BY TYPE, 2023-2030 (USD MILLION) 93
TABLE 107 CHINA: RENAL DISEASE MARKET, FOR ANTIHYPERTENSIVE DRUGS, BY TYPE, 2023-2030 (USD MILLION) 93
TABLE 108 CHINA: RENAL DISEASE MARKET, BY END USER, 2023-2030 (USD MILLION) 94
TABLE 109 INDIA: RENAL DISEASE MARKET, BY DISEASE TYPE, 2023-2030 (USD MILLION) 94
TABLE 110 INDIA: RENAL DISEASE MARKET, BY TREATMENT TYPE, 2023-2030 (USD MILLION) 95
TABLE 111 INDIA: RENAL DISEASE MARKET, FOR MEDICATION, BY TYPE, 2023-2030 (USD MILLION) 95
TABLE 112 INDIA: RENAL DISEASE MARKET, FOR ANTIHYPERTENSIVE DRUGS, BY TYPE, 2023-2030 (USD MILLION) 96
TABLE 113 INDIA: RENAL DISEASE MARKET, BY END USER, 2023-2030 (USD MILLION) 96
TABLE 114 SOUTH KOREA: RENAL DISEASE MARKET, BY DISEASE TYPE, 2023-2030 (USD MILLION) 97
TABLE 115 SOUTH KOREA: RENAL DISEASE MARKET, BY TREATMENT TYPE, 2023-2030 (USD MILLION) 97
TABLE 116 SOUTH KOREA: RENAL DISEASE MARKET, FOR MEDICATION, BY TYPE, 2023-2030 (USD MILLION) 98
TABLE 117 SOUTH KOREA: RENAL DISEASE MARKET, FOR ANTIHYPERTENSIVE DRUGS, BY TYPE, 2023-2030 (USD MILLION) 98
TABLE 118 SOUTH KOREA: RENAL DISEASE MARKET, BY END USER, 2023-2030 (USD MILLION) 99
TABLE 119 AUSTRALIA: RENAL DISEASE MARKET, BY DISEASE TYPE, 2023-2030 (USD MILLION) 99
TABLE 120 AUSTRALIA: RENAL DISEASE MARKET, BY TREATMENT TYPE, 2023-2030 (USD MILLION) 100
TABLE 121 AUSTRALIA: RENAL DISEASE MARKET, FOR MEDICATION, BY TYPE, 2023-2030 (USD MILLION) 100
TABLE 122 AUSTRALIA: RENAL DISEASE MARKET, FOR ANTIHYPERTENSIVE DRUGS, BY TYPE, 2023-2030 (USD MILLION) 101
TABLE 123 AUSTRALIA: RENAL DISEASE MARKET, BY END USER, 2023-2030 (USD MILLION) 101
TABLE 124 REST OF ASIA-PACIFIC: RENAL DISEASE MARKET, BY DISEASE TYPE, 2023-2030 (USD MILLION) 102
TABLE 125 REST OF ASIA-PACIFIC: RENAL DISEASE MARKET, BY TREATMENT TYPE, 2023-2030 (USD MILLION) 102
TABLE 126 REST OF ASIA-PACIFIC: RENAL DISEASE MARKET, FOR MEDICATION, BY TYPE, 2023-2030 (USD MILLION) 103
TABLE 127 REST OF ASIA-PACIFIC: RENAL DISEASE MARKET, FOR ANTIHYPERTENSIVE DRUGS, BY TYPE, 2023-2030 (USD MILLION) 103
TABLE 128 REST OF ASIA-PACIFIC: RENAL DISEASE MARKET, BY END USER, 2023-2030 (USD MILLION) 104
TABLE 129 MIDDLE EAST & AFRICA: RENAL DISEASE MARKET, BY REGION, 2023-2030 (USD MILLION) 105
TABLE 130 MIDDLE EAST & AFRICA: RENAL DISEASE MARKET, BY DISEASE TYPE, 2023-2030 (USD MILLION) 106
TABLE 131 MIDDLE EAST & AFRICA: RENAL DISEASE MARKET, BY TREATMENT TYPE, 2023-2030 (USD MILLION) 106
TABLE 132 MIDDLE EAST & AFRICA: RENAL DISEASE MARKET, FOR MEDICATION, BY TYPE, 2023-2030 (USD MILLION) 107
TABLE 133 MIDDLE EAST & AFRICA: RENAL DISEASE MARKET, FOR ANTIHYPERTENSIVE DRUGS, BY TYPE, 2023-2030 (USD MILLION) 107
TABLE 134 MIDDLE EAST & AFRICA: RENAL DISEASE MARKET, BY END USER, 2023-2030 (USD MILLION) 108
TABLE 135 MIDDLE EAST: RENAL DISEASE MARKET, BY DISEASE TYPE, 2023-2030 (USD MILLION) 108
TABLE 136 MIDDLE EAST: RENAL DISEASE MARKET, BY TREATMENT TYPE, 2023-2030 (USD MILLION) 109
TABLE 137 MIDDLE EAST: RENAL DISEASE MARKET, FOR MEDICATION, BY TYPE, 2023-2030 (USD MILLION) 109
TABLE 138 MIDDLE EAST: RENAL DISEASE MARKET, FOR ANTIHYPERTENSIVE DRUGS, BY TYPE, 2023-2030 (USD MILLION) 110
TABLE 139 MIDDLE EAST: RENAL DISEASE MARKET, BY END USER, 2023-2030 (USD MILLION) 110
TABLE 140 AFRICA: RENAL DISEASE MARKET, BY DISEASE TYPE, 2023-2030 (USD MILLION) 111
TABLE 141 AFRICA: RENAL DISEASE MARKET, BY TREATMENT TYPE, 2023-2030 (USD MILLION) 111
TABLE 142 AFRICA: RENAL DISEASE MARKET, FOR MEDICATION, BY TYPE, 2023-2030 (USD MILLION) 112
TABLE 143 AFRICA: RENAL DISEASE MARKET, FOR ANTIHYPERTENSIVE DRUGS, BY TYPE, 2023-2030 (USD MILLION) 113
TABLE 144 AFRICA: RENAL DISEASE MARKET, BY END USER, 2023-2030 (USD MILLION) 113
TABLE 145 TOP MANUFACTURERS IN THE GLOBAL RENAL DISEASE MARKET 115
14 List of Figures
FIGURE 1 GLOBAL RENAL DISEASE MARKET: STRUCTURE 18
FIGURE 2 RESEARCH PROCESS 20
FIGURE 3 TOP-DOWN AND BOTTOM-UP APPROACHES 23
FIGURE 4 VALUE CHAIN 30
FIGURE 5 GLOBAL RENAL DISEASE MARKET SHARE, BY DISEASE TYPE, 2020 (%) 33
FIGURE 6 GLOBAL RENAL DISEASE MARKET, BY DISEASE TYPE, 2020 & 2027 (USD MILLION) 34
FIGURE 7 GLOBAL RENAL DISEASE MARKET SHARE, BY TREATMENT TYPE, 2020 (%) 36
FIGURE 8 GLOBAL RENAL DISEASE MARKET, BY TREATMENT TYPE, 2020 & 2027 (USD MILLION) 37
FIGURE 9 GLOBAL RENAL DISEASE MARKET SHARE, BY END USER, 2020 (%) 42
FIGURE 10 GLOBAL RENAL DISEASE MARKET, BY END USER, 2020 & 2027 (USD MILLION) 42
FIGURE 11 GLOBAL RENAL DISEASE MARKET SHARE, BY REGION, 2020 (%) 46
FIGURE 12 GLOBAL RENAL DISEASE MARKET, BY REGION, 2020 & 2027 (USD MILLION) 46
FIGURE 13 AMERICAS: RENAL DISEASE MARKET SHARE, BY REGION, 2020 (%) 48
FIGURE 14 EUROPE: RENAL DISEASE MARKET SHARE, BY REGION, 2020 (%) 62
FIGURE 15 WESTERN EUROPE: RENAL DISEASE MARKET SHARE, BY COUNTRY, 2020 (%) 65
FIGURE 16 ASIA-PACIFIC: RENAL DISEASE MARKET SHARE, BY COUNTRY, 2020 (%) 87
FIGURE 17 MIDDLE EAST & AFRICA: RENAL DISEASE MARKET SHARE, BY REGION, 2020 (%) 105
Research Analyst Level I He is an extremely curious individual currently working in healthcare and medical devices domain. kinjoll is comfortably versed in data centric research backed by healthcare educational background. he leverages extensive data mining and analytics tools such as primary and secondary research, statistical analysis, machine learning, data modelling. his key role also involves technical sales support, client interaction and project management within the healthcare team. lastly, he showcases extensive affinity towards learning new skills and remain fascinated in implementing them.
Get in Touch
© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)
